SYRE vs VRTX: Which Stock is Better?
Side-by-side comparison of Spyre Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026
SYRE
Spyre Therapeutics Inc
$73.01
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | SYRE | VRTX | Winner |
|---|---|---|---|
| Market Cap | $5.94B | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze SYRE
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRE or VRTX a better investment?
Comparing SYRE and VRTX: Spyre Therapeutics Inc has a market cap of $5.94B while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRE and VRTX?
SYRE (Spyre Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRE or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRE or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for SYRE.
Which company is more profitable: SYRE or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for SYRE.
Which is the larger company: SYRE or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $5.94B for SYRE.
Should I buy SYRE or VRTX in 2026?
Both SYRE and VRTX have investment merit. SYRE trades at $73.01 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRE and VRTX stock?
Key differences: Market Cap ($5.94B vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).